PRESS & NEWS

ASPIRE-FTD Trial Expands to Fourth Cohort

AviadoBio has expanded its ASPIRE-FTD clinical trial, creating new opportunities for people with GRN mutations to participate in gene therapy research.

Quick Question February 2026 Result:

534 individuals responded, providing insight into how symptoms of FTD can sometimes intersect with law enforcement

What Care Partners Teach Researchers

Care partners play a vital role in helping researchers understand how the impact of FTD unfolds in daily life. Through their observations, experiences, and participation in the FTD Disorders Registry, care partners provide insights that shape future studies and ensure research reflects the real challenges families face.

Louder Than Words: CurePSP Helps People Preserve Their Voice

CurePSP’s Louder Than Words program provides free voice banking and AI voice cloning tools for people living with PSP, CBD, and MSA, helping individuals preserve their voice and stay connected with loved ones even if speech becomes difficult.

FTD Is Not One Disease: Why Subtypes Matter for Research

FTD is a spectrum, not a single diagnosis. Recognizing the differences between subtypes helps researchers design smarter studies, accelerate discoveries, and move us closer to effective treatments.

Together we can find a cure for ftd

The FTD Disorders Registry is a powerful tool in the movement to create therapies and find a cure. Together we can help change the course of the disease and put an end to FTD.

Your privacy is important! We promise to protect it. We will not share your contact information.

Read Full Privacy Statement